IS5021A - Notkun samsetningar H+, K+ -ATPasa tálma og sykurstera í meðhöndlun á nefsepagerum - Google Patents

Notkun samsetningar H+, K+ -ATPasa tálma og sykurstera í meðhöndlun á nefsepagerum

Info

Publication number
IS5021A
IS5021A IS5021A IS5021A IS5021A IS 5021 A IS5021 A IS 5021A IS 5021 A IS5021 A IS 5021A IS 5021 A IS5021 A IS 5021A IS 5021 A IS5021 A IS 5021A
Authority
IS
Iceland
Prior art keywords
glucocorticosteroids
pagers
nasal
combinations
treatment
Prior art date
Application number
IS5021A
Other languages
English (en)
Other versions
IS1930B (is
Inventor
Lindberg Per
Pinas-Masso Joan
Serra-Carreras Jordi
Trofast Jan
Original Assignee
Astrazeneca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca filed Critical Astrazeneca
Publication of IS5021A publication Critical patent/IS5021A/is
Publication of IS1930B publication Critical patent/IS1930B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
IS5021A 1996-10-11 1999-04-08 Notkun samsetningar H+, K+ -ATPasa tálma og sykurstera í meðhöndlun á nefsepagerum IS1930B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9603725A SE9603725D0 (sv) 1996-10-11 1996-10-11 New teatment
PCT/SE1997/001651 WO1998016228A1 (en) 1996-10-11 1997-10-01 USE OF AN H+, K+-ATPase INHIBITOR IN THE TREATMENT OF NASAL POLYPS

Publications (2)

Publication Number Publication Date
IS5021A true IS5021A (is) 1999-04-08
IS1930B IS1930B (is) 2004-05-18

Family

ID=20404214

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5021A IS1930B (is) 1996-10-11 1999-04-08 Notkun samsetningar H+, K+ -ATPasa tálma og sykurstera í meðhöndlun á nefsepagerum

Country Status (34)

Country Link
EP (1) EP0946175B1 (is)
JP (1) JP4100713B2 (is)
KR (1) KR100510812B1 (is)
CN (1) CN1146416C (is)
AR (1) AR008886A1 (is)
AT (1) ATE230597T1 (is)
AU (1) AU738310B2 (is)
BR (1) BR9711896A (is)
CA (1) CA2268305C (is)
CZ (1) CZ298799B6 (is)
DE (1) DE69718347T2 (is)
DK (1) DK0946175T3 (is)
EE (1) EE04043B1 (is)
ES (1) ES2188995T3 (is)
HK (1) HK1022848A1 (is)
HU (1) HUP0000036A3 (is)
ID (1) ID23692A (is)
IL (1) IL129324A0 (is)
IS (1) IS1930B (is)
MY (1) MY117918A (is)
NO (1) NO321007B1 (is)
NZ (1) NZ334786A (is)
PL (1) PL190902B1 (is)
PT (1) PT946175E (is)
RS (1) RS49599B (is)
RU (1) RU2197966C2 (is)
SA (1) SA97180641B1 (is)
SE (1) SE9603725D0 (is)
SK (1) SK284252B6 (is)
TR (1) TR199900770T2 (is)
TW (1) TW568784B (is)
UA (1) UA59374C2 (is)
WO (1) WO1998016228A1 (is)
ZA (1) ZA978842B (is)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6846799B1 (en) * 1998-08-18 2005-01-25 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
CZ2001584A3 (cs) 1998-08-18 2002-06-12 The Regents Of The University Of California Prevence tvorby hlenu v dýchacích cestách podáváním antagonistů EGF-R
US7354894B2 (en) 1998-08-18 2008-04-08 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
CA2467652A1 (en) * 2001-11-19 2003-05-30 Altana Pharma Ag Reversible proton pump inhibitors for the treatment of airway disorders
US20050131026A1 (en) * 2002-03-14 2005-06-16 Atlanta Pharma Ag Use of proton pump inhibitors for the treatment of airway disorders
EP1517706A2 (en) * 2002-05-07 2005-03-30 ALTANA Pharma AG Combination of a proton pump inhibitor and a respiratory agent for the treatment of respiratory diseases
US20050222193A1 (en) * 2002-05-07 2005-10-06 Guido Hanauer Novel combination for the treatment of airway disorders
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
AU2003293833B2 (en) 2002-12-12 2009-10-01 Covis Pharma B.V. Combination medicament
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN104408249B (zh) * 2014-11-24 2017-09-26 广州供电局有限公司 单芯电缆导体热性参数的确定方法及系统
KR101974504B1 (ko) * 2017-04-10 2019-05-03 재단법인 아산사회복지재단 호산구성 비용종 동물모델

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate

Also Published As

Publication number Publication date
MY117918A (en) 2004-08-30
SE9603725D0 (sv) 1996-10-11
TR199900770T2 (xx) 1999-06-21
EP0946175B1 (en) 2003-01-08
CZ122999A3 (cs) 1999-09-15
RU2197966C2 (ru) 2003-02-10
EE04043B1 (et) 2003-06-16
AU4640997A (en) 1998-05-11
SK284252B6 (sk) 2004-12-01
UA59374C2 (uk) 2003-09-15
RS49599B (sr) 2007-06-04
AR008886A1 (es) 2000-02-23
WO1998016228A1 (en) 1998-04-23
HUP0000036A3 (en) 2003-02-28
BR9711896A (pt) 1999-08-24
IL129324A0 (en) 2000-02-17
YU16399A (sh) 2000-03-21
HUP0000036A2 (hu) 2002-05-29
HK1022848A1 (en) 2000-08-25
KR100510812B1 (ko) 2005-08-31
AU738310B2 (en) 2001-09-13
NO321007B1 (no) 2006-02-27
IS1930B (is) 2004-05-18
NO991619D0 (no) 1999-04-06
HU0000036D0 (is) 2002-05-29
EP0946175A1 (en) 1999-10-06
PL190902B1 (pl) 2006-02-28
SA97180641B1 (ar) 2005-12-18
DK0946175T3 (da) 2003-03-17
NZ334786A (en) 2000-12-22
KR20000049046A (ko) 2000-07-25
CA2268305C (en) 2006-11-28
JP4100713B2 (ja) 2008-06-11
CN1232397A (zh) 1999-10-20
EE9900118A (et) 1999-10-15
DE69718347T2 (de) 2003-08-28
NO991619L (no) 1999-04-06
CN1146416C (zh) 2004-04-21
CA2268305A1 (en) 1998-04-23
PT946175E (pt) 2003-04-30
PL332692A1 (en) 1999-09-27
CZ298799B6 (cs) 2008-02-06
SK38499A3 (en) 2000-03-13
TW568784B (en) 2004-01-01
JP2001508034A (ja) 2001-06-19
DE69718347D1 (de) 2003-02-13
ZA978842B (en) 1998-04-14
ATE230597T1 (de) 2003-01-15
ID23692A (id) 2000-05-11
ES2188995T3 (es) 2003-07-01

Similar Documents

Publication Publication Date Title
IS5021A (is) Notkun samsetningar H+, K+ -ATPasa tálma og sykurstera í meðhöndlun á nefsepagerum
NO20004098D0 (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
IS5405A (is) Prostaglandín gerandefni og notkun þeirra til að meðhöndla beintruflanir
NO990965D0 (no) Terapeutiske fremgangsmÕter og blandinger som inneholder isoflavoner
IS5756A (is) Notkun hreinljósvirks (+) -norkisapríðs við meðhöndlun á öndunarstöðvun, lotugræðgi og öðrum meinum
IS5921A (is) Staðgengnar Bensópýrahliðstæður til notkunar við meðhöndlun á bólgu
NO972125D0 (no) Hemmoroideblandinger og fremgangsmåte for anvendelse
EE200100480A (et) Ksenoon kasutamiseks närvimürgistuste ravis
IS5696A (is) Mótefni gegn CD23, afleiður þeirra og meðferðarnotkun þeirra
IS1995B (is) Tríazól afleiður, gagnlegar í meðhöndlun
DE69527749D1 (de) Kugelförmige Aktivkohle zur Behandlung von Bauchentzündungen
NO983576D0 (no) Brönnbehandlingsfluider og fremgangsmåter
IS6874A (is) 3,7-díasabísýkló[3.3.0]oktön og notkun þeirra í meðhöndlun á hjartsláttarglöpum
IS2207B (is) Karbósýklískt kirnisleifar hemisúlfat og notkun þess við meðhöndlun á veirusýkingum
IS3632A7 (is) Benzodíazepín, aðferð og milliefni við framleiðslu þeirra, og notkun þeirra við lækningar
EE9800333A (et) Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias
IS4924A (is) Píperidín ediksýruafleiður og notkun þeirra við meðhöndlun á segamyndunar truflunum
NO992690D0 (no) Nye calpainer, fremstilling og anvendelse derav
HK1044468A1 (zh) 治療哮喘和炎症的小肽和方法
IS6660A (is) Ný bispídínefnasambönd og notkun þeirra í meðhöndlun á hjartsláttarglöpum
DK1140803T3 (da) ((aminoiminomethyl)amino)alkancarboxamider og anvendelse deraf i terapi
NO20022482D0 (no) 2-arylkinolinderivater, fremgangsmåte og terapeutisk anvendelse derav
NO20015922D0 (no) Nye calpainer og anvendelse derav
SI0946175T1 (en) USE OF A COMBINATION OF H+, K+ -ATPase INHIBITORS AND GLUCOCORTICOIDS IN THE TREATMENT OF NASAL POLYPS
DK1047668T3 (da) Triazepinoner, fremgangsmåde til fremstilling deraf og terapeutisk anvendelse deraf